2025 Investor Day 2

Veeva
arc beats above · slides in the middle · loops below · scroll → 0 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

1
coverage by narrative range · generated from this deck JSON
Narrative range 51 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Whole deck 51 slides 100% 51/51 slides 100% 51/51 slides · 210 hits
0/51 slides
39.2% 20/51 slides · 21 hits 15.7% 8/51 slides
0/51 slides
0/51 slides

Slide inventory

51
every slide · same image gating as the playbook
01
Slide 1
front_matter
02
front_matter
03
front_matter
05
summarize
06
summarize
07
size_opportunity
08
The slide uses a visual metaphor of a small circle (1% of $2T+) expanding into a larger $20B+ TAM circle.size_opportunity
09
summarize
10
summarize
11
The slide uses a modular layout to represent the company's service offerings.present_framework
12
The slide uses a layered architecture diagram to show how specific functional modules (Clinical Ops, Data, Regulatory, Safety) sit atop the core Vault Platform.present_framework
13
The slide uses a simple two-column framework to categorize software modules.present_framework
14
The slide uses a layered architecture metaphor, with the Vault Platform as the base and various functional modules (CRM, Content, Medical, etc.) as the applicatpresent_framework
15
summarize
16
The slide displays four main product pillars: OpenData, HCP 360, Link, and Compass, all built on a Common Data Architecture.present_solution
17
summarize
18
front_matter
19
transition
20
front_matter
21
The slide uses a circular diagram to represent the unification of data and content, supported by three key platform pillars.present_solution
22
The slide uses a circular diagram to represent the synergy between Data, Content, and Agents.present_framework
23
summarize
24
This appears to be a transition or placeholder slide for a live demo.filler
25
plan_implementation
26
summarize
27
transition
28
size_opportunity
29
present_solution
30
summarize
31
prioritize
32
summarize
34
transition
35
Includes a disclaimer regarding FX assumptions and non-GAAP reconciliation.summarize
36
The chart visualizes revenue concentration, highlighting the dominance of the Biopharma segment.decompose_segments
37
The slide compares current run rate, revenue breakdown, and operating margin against long-term goals.summarize
38
The slide uses a stacked bar chart to represent market segments and a callout box for the total TAM and penetration.size_opportunity
39
The chart shows a shift in revenue mix, with Clinical and Quality segments growing as a percentage of the total.quantify_impact
40
The chart uses a bubble-like scatter plot approach within a 2x2 grid structure.present_framework
41
The chart uses a grouped bar format to compare two financial metrics over time, with FY26 marked as an estimate.quantify_impact
42
The slide includes a list of strategic focus areas (Product Excellence, Customer Success, Reference Selling) alongside the expense breakdown.analyze_data
43
summarize
47
The chart tracks customer growth across three segments: 5+ products, 3-4 products, and 2 products or fewer, from FY21 to Q2'26.quantify_impact
48
The chart tracks customer count by product adoption tiers (8+, 4-7, 3 or fewer) from FY21 to Q2'26, alongside the average products per customer metric.quantify_impact
50
Fiscal year ends January 31.summarize
51
Fiscal Year Ending January 31analyze_data